246 related articles for article (PubMed ID: 28550687)
1. Tanshinone Suppresses Arecoline-Induced Epithelial-Mesenchymal Transition in Oral Submucous Fibrosis by Epigenetically Reactivating the p53 Pathway.
Zheng L; Guan ZJ; Pan WT; Du TF; Zhai YJ; Guo J
Oncol Res; 2018 Apr; 26(3):483-494. PubMed ID: 28550687
[TBL] [Abstract][Full Text] [Related]
2. Arecoline-induced myofibroblast transdifferentiation from human buccal mucosal fibroblasts is mediated by ZEB1.
Chang YC; Tsai CH; Lai YL; Yu CC; Chi WY; Li JJ; Chang WW
J Cell Mol Med; 2014 Apr; 18(4):698-708. PubMed ID: 24400868
[TBL] [Abstract][Full Text] [Related]
3. Augmented mRNA expression of tissue inhibitor of metalloproteinase-1 in buccal mucosal fibroblasts by arecoline and safrole as a possible pathogenesis for oral submucous fibrosis.
Shieh DH; Chiang LC; Shieh TY
Oral Oncol; 2003 Oct; 39(7):728-35. PubMed ID: 12907213
[TBL] [Abstract][Full Text] [Related]
4. miR-200b ameliorates myofibroblast transdifferentiation in precancerous oral submucous fibrosis through targeting ZEB2.
Liao YW; Yu CC; Hsieh PL; Chang YC
J Cell Mol Med; 2018 Sep; 22(9):4130-4138. PubMed ID: 29893466
[TBL] [Abstract][Full Text] [Related]
5. E3 ligase carboxyl-terminus of Hsp70-interacting protein (CHIP) suppresses fibrotic properties in oral mucosa.
Chen SC; Liu CM; Hsieh PL; Liao YW; Lin YJ; Yu CC; Yu CH
J Formos Med Assoc; 2020 Feb; 119(2):595-600. PubMed ID: 31653576
[TBL] [Abstract][Full Text] [Related]
6. Epithelial atrophy in oral submucous fibrosis is mediated by copper (II) and arecoline of areca nut.
Khan I; Pant I; Narra S; Radhesh R; Ranganathan K; Rao SG; Kondaiah P
J Cell Mol Med; 2015 Oct; 19(10):2397-412. PubMed ID: 26248978
[TBL] [Abstract][Full Text] [Related]
7. Arecoline-stimulated connective tissue growth factor production in human buccal mucosal fibroblasts: Modulation by curcumin.
Deng YT; Chen HM; Cheng SJ; Chiang CP; Kuo MY
Oral Oncol; 2009 Sep; 45(9):e99-e105. PubMed ID: 19457704
[TBL] [Abstract][Full Text] [Related]
8. Arecoline inhibits epithelial cell viability by upregulating the apoptosis pathway: implication for oral submucous fibrosis.
Li M; Gao F; Zhou ZS; Zhang HM; Zhang R; Wu YF; Bai MH; Li JJ; Lin SR; Peng JY
Oncol Rep; 2014 May; 31(5):2422-8. PubMed ID: 24647969
[TBL] [Abstract][Full Text] [Related]
9. Elevation of S100A4 expression in buccal mucosal fibroblasts by arecoline: involvement in the pathogenesis of oral submucous fibrosis.
Yu CC; Tsai CH; Hsu HI; Chang YC
PLoS One; 2013; 8(1):e55122. PubMed ID: 23383075
[TBL] [Abstract][Full Text] [Related]
10. Elevation of Twist expression by arecoline contributes to the pathogenesis of oral submucous fibrosis.
Lee YH; Yang LC; Hu FW; Peng CY; Yu CH; Yu CC
J Formos Med Assoc; 2016 May; 115(5):311-7. PubMed ID: 26088962
[TBL] [Abstract][Full Text] [Related]
11. Raised keratinocyte growth factor-1 expression in oral submucous fibrosis in vivo and upregulated by arecoline in human buccal mucosal fibroblasts in vitro.
Tsai CH; Yang SF; Chen YJ; Chou MY; Chang YC
J Oral Pathol Med; 2005 Feb; 34(2):100-5. PubMed ID: 15641989
[TBL] [Abstract][Full Text] [Related]
12. Elevated vimentin expression in buccal mucosal fibroblasts by arecoline in vitro as a possible pathogenesis for oral submucous fibrosis.
Chang YC; Tsai CH; Tai KW; Yang SH; Chou MY; Lii CK
Oral Oncol; 2002 Jul; 38(5):425-30. PubMed ID: 12110335
[TBL] [Abstract][Full Text] [Related]
13. Hypoxic regulation of plasminogen activator inhibitor-1 expression in human buccal mucosa fibroblasts stimulated with arecoline.
Tsai CH; Lee SS; Chang YC
J Oral Pathol Med; 2015 Oct; 44(9):669-73. PubMed ID: 25367145
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of HIF1A-AS1 impedes the arecoline-induced migration activity of human oral mucosal fibroblasts.
Wang YK; Liu CM; Lin T; Fang CY; Yu CC; Yu CH
J Formos Med Assoc; 2020 Apr; 119(4):879-883. PubMed ID: 31959495
[TBL] [Abstract][Full Text] [Related]
15. miR-203 inhibits arecoline-induced epithelial-mesenchymal transition by regulating secreted frizzled-related protein 4 and transmembrane-4 L six family member 1 in oral submucous fibrosis.
Zheng L; Jian X; Guo F; Li N; Jiang C; Yin P; Min AJ; Huang L
Oncol Rep; 2015 Jun; 33(6):2753-60. PubMed ID: 25872484
[TBL] [Abstract][Full Text] [Related]
16. Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis.
Moutasim KA; Jenei V; Sapienza K; Marsh D; Weinreb PH; Violette SM; Lewis MP; Marshall JF; Fortune F; Tilakaratne WM; Hart IR; Thomas GJ
J Pathol; 2011 Feb; 223(3):366-77. PubMed ID: 21171082
[TBL] [Abstract][Full Text] [Related]
17. Acquisition cancer stemness, mesenchymal transdifferentiation, and chemoresistance properties by chronic exposure of oral epithelial cells to arecoline.
Wang TY; Peng CY; Lee SS; Chou MY; Yu CC; Chang YC
Oncotarget; 2016 Dec; 7(51):84072-84081. PubMed ID: 27557511
[TBL] [Abstract][Full Text] [Related]
18. Effects of arecoline, safrole, and nicotine on collagen phagocytosis by human buccal mucosal fibroblasts as a possible mechanism for oral submucous fibrosis in Taiwan.
Shieh DH; Chiang LC; Lee CH; Yang YH; Shieh TY
J Oral Pathol Med; 2004 Oct; 33(9):581-7. PubMed ID: 15357680
[TBL] [Abstract][Full Text] [Related]
19. Areca nut-induced buccal mucosa fibroblast contraction and its signaling: a potential role in oral submucous fibrosis--a precancer condition.
Chang MC; Lin LD; Wu HL; Ho YS; Hsien HC; Wang TM; Jeng PY; Cheng RH; Hahn LJ; Jeng JH
Carcinogenesis; 2013 May; 34(5):1096-104. PubMed ID: 23349021
[TBL] [Abstract][Full Text] [Related]
20. The upregulation of type I plasminogen activator inhibitor in oral submucous fibrosis.
Yang SF; Hsieh YS; Tsai CH; Chou MY; Chang YC
Oral Oncol; 2003 Jun; 39(4):367-72. PubMed ID: 12676256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]